Overview

A Study of Naltrexone SR/ Bupropion SR in Overweight or Obese Subjects With Major Depression

Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether a combination of naltrexone SR and bupropion SR is safe and effective in the treatment of major depression in overweight or obese subjects.
Phase:
Phase 2
Details
Lead Sponsor:
Orexigen Therapeutics, Inc
Treatments:
Bupropion
Naltrexone